WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 4'7201 Infant (under 12 months) mortality rate: 182
GDP / capita (US$): 6'1481 Child (under 5 years) mortality rate: 212

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 7'009  6'731  6'455  6'181  5'911  4'767  3'358  2'281 
Births 192  190  186  182  178  148  119  95 
Surviving infants 189  186  183  179  174  145  115  91 
Pop. less than 5 years 937  906  862  827  788  694  559  422 
Pop. less than 15 years 2'413  2'343  2'265  2'201  2'136  1'877  1'552  1'117 
Female 15-49 years 1'873  1'791  1'711  1'628  1'546  1'145  685  450 

Number of reported case

(Click for retrospective incidence data for Jordan)
Diphtheria
Japanese encephalitis
Measles 32  290  552 
Mumps 194  175  162  150  193  16'122 
Pertussis 437 
Polio* 15 
Rubella 165 
Rubella (CRS)
Tetanus (neonatal) 23 
Tetanus (total) 46 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Jordan)
Vaccine year result method % card seen                                                
BCG 2011  98  DHS   80.4  96  95  95  95  95  32 
DTP1 2011  100  DHS   80.4  98  98  98  98  98  89 
DTP3 2011  98  DHS   80.4  98  98  98  98  97  91  92  30 
HepB_BD         
HepB3          98  98  98  98  97  93 
Hib3          98  98  98  98  97 
JapEnc         
MCV 2011  94  DHS   80.4  98  98  98  95  95  94  87  29 
MCV2          96  95  95  90  90  83 
PCV1          90 
PCV3         
Pol3 2011  98  DHS   80.4  98  98  98  98  98  94  92  32 
Rota1         
Rota_last         
Rubella1          97  90  90  90  90 
TT2plus 2001  DHS   77.6  85  85  85  85  85  23 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Jordan)
BCG 96  95  95  95  95 
DTP1 98  98  98  98  98  91  97  55 
DTP3 98  98  98  98  97  91  92  30 
HepB3 98  98  98  98  97  93 
Hib3 98  98  98  98  97 
MCV 98  98  98  95  95  94  87  29 
PAB 90  90  87  87  87  44  49 
PCV3
Pol3 98  98  98  98  98  94  92  32 
Rota_last

Number of districts in the country 12  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 0-6 years; Yes
DT 3, 4, 5, 18 months; Yes
DTaPHibIPV 3, 4, 5 months; Yes
DTwP 18 months; Yes
HepB 3, 4, 5 months; Yes And adults at risk
IPV 3, 4, 5 months; Yes
Influenza Yes HCW, Pilgrims, high risk group
MMR 12, 18 months; Yes
Measles 9 months; Yes
MenACWY > 2 years; Yes contacts, pilgrims
OPV 4, 5, 9, 18 months; 6 years; Yes
Pneumo_conj 3, 5 months; Yes
TT 1st contact; +1, +6 months; +1, +1 year; Yes
Td 6, 16 years; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR No  No  No  No  No  No  No 
What years does the MYP cover? number             NA 
Nº of districts with microplans that include activities to raise immunization coverage number 12  12  12  12  21  21   

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 12  12  12  21  21  21  21 
Nº districts with DTP3 coverage >=80% number 12  12  12  21  21  21  21 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 10  11  18  21     
% of districts with MCV1 coverage >=95% From 0 to 100% 75  83  92  86  100     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.